CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

10.1007/s10549-018-5027-0

Saved in:
Bibliographic Details
Main Authors: Drogemoller, Britt I, Wright, Galen EB, Shih, Joanne, Monzon, Jose G, Gelmon, Karen A, Ross, Colin JD, Amstutz, Ursula, Carleton, Bruce C, Chang, Wan C, Connolly, Mary B, Dionne, Francois, Groeneweg, Gabriella, Loucks, Catrina M, MacLeod, Stuart M, Pritchard, Sheila, Rassekh, Shahrad R, Sanatani, Shubhayan, Bhavsar, Amit P, Rieder, Michael J, Shear, Neil H, Ito, Shinya, Liu, Geoffrey, Khayat, Philip, Bernstein, Daniel, Lesko, Lawrence J, Aminkeng, Folefac
Other Authors: MEDICINE
Format: Review
Language:English
Published: SPRINGER 2022
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/235040
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-235040
record_format dspace
spelling sg-nus-scholar.10635-2350402024-04-18T01:07:06Z CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines Drogemoller, Britt I Wright, Galen EB Shih, Joanne Monzon, Jose G Gelmon, Karen A Ross, Colin JD Amstutz, Ursula Carleton, Bruce C Chang, Wan C Connolly, Mary B Dionne, Francois Groeneweg, Gabriella Loucks, Catrina M MacLeod, Stuart M Pritchard, Sheila Rassekh, Shahrad R Sanatani, Shubhayan Bhavsar, Amit P Rieder, Michael J Shear, Neil H Ito, Shinya Liu, Geoffrey Khayat, Philip Bernstein, Daniel Lesko, Lawrence J Aminkeng, Folefac MEDICINE Science & Technology Life Sciences & Biomedicine Oncology Clinical practice guidelines CYP2D6 Pharmacogenomics Systematic review Tamoxifen TAMOXIFEN DOSE-ESCALATION BONE-MINERAL DENSITY ESTROGEN-RECEPTOR POSTMENOPAUSAL WOMEN AROMATASE INHIBITORS ENDOXIFEN CONCENTRATIONS LEVEL METAANALYSIS ACTIVE METABOLITE GENOTYPE THERAPY 10.1007/s10549-018-5027-0 BREAST CANCER RESEARCH AND TREATMENT 173 3 521-532 2022-12-01T03:38:06Z 2022-12-01T03:38:06Z 2019-02-01 2022-11-30T16:07:40Z Review Drogemoller, Britt I, Wright, Galen EB, Shih, Joanne, Monzon, Jose G, Gelmon, Karen A, Ross, Colin JD, Amstutz, Ursula, Carleton, Bruce C, Chang, Wan C, Connolly, Mary B, Dionne, Francois, Groeneweg, Gabriella, Loucks, Catrina M, MacLeod, Stuart M, Pritchard, Sheila, Rassekh, Shahrad R, Sanatani, Shubhayan, Bhavsar, Amit P, Rieder, Michael J, Shear, Neil H, Ito, Shinya, Liu, Geoffrey, Khayat, Philip, Bernstein, Daniel, Lesko, Lawrence J, Aminkeng, Folefac (2019-02-01). CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines. BREAST CANCER RESEARCH AND TREATMENT 173 (3) : 521-532. ScholarBank@NUS Repository. https://doi.org/10.1007/s10549-018-5027-0 0167-6806 1573-7217 https://scholarbank.nus.edu.sg/handle/10635/235040 en SPRINGER Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Oncology
Clinical practice guidelines
CYP2D6
Pharmacogenomics
Systematic review
Tamoxifen
TAMOXIFEN DOSE-ESCALATION
BONE-MINERAL DENSITY
ESTROGEN-RECEPTOR
POSTMENOPAUSAL WOMEN
AROMATASE INHIBITORS
ENDOXIFEN CONCENTRATIONS
LEVEL METAANALYSIS
ACTIVE METABOLITE
GENOTYPE
THERAPY
spellingShingle Science & Technology
Life Sciences & Biomedicine
Oncology
Clinical practice guidelines
CYP2D6
Pharmacogenomics
Systematic review
Tamoxifen
TAMOXIFEN DOSE-ESCALATION
BONE-MINERAL DENSITY
ESTROGEN-RECEPTOR
POSTMENOPAUSAL WOMEN
AROMATASE INHIBITORS
ENDOXIFEN CONCENTRATIONS
LEVEL METAANALYSIS
ACTIVE METABOLITE
GENOTYPE
THERAPY
Drogemoller, Britt I
Wright, Galen EB
Shih, Joanne
Monzon, Jose G
Gelmon, Karen A
Ross, Colin JD
Amstutz, Ursula
Carleton, Bruce C
Chang, Wan C
Connolly, Mary B
Dionne, Francois
Groeneweg, Gabriella
Loucks, Catrina M
MacLeod, Stuart M
Pritchard, Sheila
Rassekh, Shahrad R
Sanatani, Shubhayan
Bhavsar, Amit P
Rieder, Michael J
Shear, Neil H
Ito, Shinya
Liu, Geoffrey
Khayat, Philip
Bernstein, Daniel
Lesko, Lawrence J
Aminkeng, Folefac
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
description 10.1007/s10549-018-5027-0
author2 MEDICINE
author_facet MEDICINE
Drogemoller, Britt I
Wright, Galen EB
Shih, Joanne
Monzon, Jose G
Gelmon, Karen A
Ross, Colin JD
Amstutz, Ursula
Carleton, Bruce C
Chang, Wan C
Connolly, Mary B
Dionne, Francois
Groeneweg, Gabriella
Loucks, Catrina M
MacLeod, Stuart M
Pritchard, Sheila
Rassekh, Shahrad R
Sanatani, Shubhayan
Bhavsar, Amit P
Rieder, Michael J
Shear, Neil H
Ito, Shinya
Liu, Geoffrey
Khayat, Philip
Bernstein, Daniel
Lesko, Lawrence J
Aminkeng, Folefac
format Review
author Drogemoller, Britt I
Wright, Galen EB
Shih, Joanne
Monzon, Jose G
Gelmon, Karen A
Ross, Colin JD
Amstutz, Ursula
Carleton, Bruce C
Chang, Wan C
Connolly, Mary B
Dionne, Francois
Groeneweg, Gabriella
Loucks, Catrina M
MacLeod, Stuart M
Pritchard, Sheila
Rassekh, Shahrad R
Sanatani, Shubhayan
Bhavsar, Amit P
Rieder, Michael J
Shear, Neil H
Ito, Shinya
Liu, Geoffrey
Khayat, Philip
Bernstein, Daniel
Lesko, Lawrence J
Aminkeng, Folefac
author_sort Drogemoller, Britt I
title CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
title_short CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
title_full CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
title_fullStr CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
title_full_unstemmed CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
title_sort cyp2d6 as a treatment decision aid for er-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
publisher SPRINGER
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/235040
_version_ 1800915742065950720